Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStatPro Regulatory News (SOG)

  • There is currently no data for SOG

Director/PDMR Shareholding

30 Mar 2011 16:25

RNS Number : 9483D
Statpro Group PLC
30 March 2011
 



 

 

For immediate release 30 March 2011

 

STATPRO GROUP PLC

("StatPro" or the "Group")

 

Directors' dealings

Exercise and Net settlement of Share Options

 

Grant of options

StatPro Group plc (AIM:SOG), the AIM listed provider of portfolio analytics and data solutions for the global asset management industry, today announces the grant of share options over a total of 600,000 ordinary shares of 1p each in the Company ("Ordinary Shares") to directors and senior employees in the Group.

 

The options are exercisable at 130p per share being a premium of 10% over the closing mid-market share price of 118p per Ordinary Share on 29 March 2011. Exercise of the options is conditional upon the satisfaction of performance conditions. The options will not be exercisable unless the share price equals or exceeds 145p per share for a period of at least twenty consecutive trading days and specified targets of growth in earnings per share are met. The share options are exercisable at any time between 29 March 2014 and 29 March 2018 being a period of between three years and seven years from the date of grant, subject to the satisfaction of the performance conditions.

 

The grants of options include grants to StatPro's executive directors over the following numbers of shares:

 

Justin Wheatley, Chief Executive 35,000

Andrew Fabian, Finance Director 35,000

 

Exercise and Net settlement of Share Options

Following the receipt by the Company of applications relating to the exercise of options over 140,583 shares at exercise prices of 60p or 61p under Company share option schemes, the Company has opted to net settle 74,500 options by cash settlement in order to reduce the impact of dilution. The net settlement value was determined by the Board as 118p per ordinary share. As a result, cash amounting to a total of approximately £43,000 including option tax liability has been paid and 66,083 shares have been issued. Application has been made for the admission to AIM of 66,083 new Ordinary Shares. It is expected that dealings will commence on 5 April 2011. These shares will rank pari passu with the Group's existing issued Ordinary Shares.

 

Within this total, Andrew Fabian, Finance Director, exercised on 29 March 2011 35,000 options at 60p per share and subsequently sold 35,000 shares today at 116.4p per share from his SIPP resulting in no beneficial change to his holdings.

 

Other director dealings

The Company was informed today that on 29 March 2011 Mark Adorian, Non-Executive Director, purchased 120,000 Ordinary Shares and his wife sold 120,000 Ordinary Shares at 118p per share resulting in no beneficial change to his holdings.

 

The Company was informed today that Charles Fairbairn, Non-Executive Director, purchased 24,400 Ordinary Shares today in his SIPP at 117.5p per share and sold today 24,400 Ordinary Shares in his own name at 117.5p per share resulting in no beneficial change to his holdings.

 

Following these allocations and transactions Justin Wheatley is interested in 7,159,367 Ordinary Shares representing approximately 11.78% of the Company's issued ordinary share capital and options over 1,170,000 Ordinary Shares. Andrew Fabian is interested in 207,795 Ordinary Shares representing approximately 0.34% of the Company's issued Ordinary Share capital and options over 182,000 Ordinary Shares. Mark Adorian is interested in 2,520,698 Ordinary Shares representing approximately 4.15% of the Company's issued Ordinary Share capital. Charles Fairbairn is interested in 779,834 Ordinary Shares representing approximately 1.28% of the Company's issued Ordinary Share capital.

 

Voting rights

Following Admission, the Company's enlarged issued share capital will comprise 60,793,315 Ordinary Shares with voting rights and the Company holds 225,000 shares in treasury. This figure of 60,793,315 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.

 

- Ends -

 

For further information, please contact:

 

StatPro Group plc

www.statpro.com

Justin Wheatley, Chief Executive

020 8410 9876

Andrew Fabian, Finance Director

 

Cenkos Securities

Ken Fleming (NOMAD)

0131 220 6939

Jon Fitzpatrick (NOMAD)

0207 397 8900

Julian Morse (Broker)

020 7397 1931

Threadneedle Communications

Caroline Evans-Jones/ Tom Moriarty/ Hilary Millar

 

020 7653 9850

 

About StatPro

StatPro is a leading provider of portfolio analytics and data solutions for the global asset management industry. The Company sells a SaaS-based Analytics and Data platform on a rental basis to investment management companies allowing them to analyse portfolio performance, attribution, risk and GIPS® compliance. StatPro also provides market data and valuation feeds including a Complex Asset Pricing service.

StatPro has grown its recurring revenue from less than ÂŁ1 million in 1999 to ÂŁ29 million at end December 2010 and currently enjoys a renewal rate of approximately 92%. StatPro floated on the London Stock Exchange in May 2000 and transferred its listing in June 2003 to AIM. The Company has operations in Europe, North America, South Africa and Australia, with approximately 79% of recurring revenues being generated outside the UK.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSDUFISFFSEFD
Date   Source Headline
30th Dec 20146:20 pmRNSIssue of Shares
21st Nov 20147:00 amRNSDirector's dealings
20th Nov 20147:00 amRNS5 year contract renewal with global asset manager
6th Nov 20147:00 amRNSStatPro signs referral partner in Korea
28th Oct 20149:52 amRNSDirectors' dealings
27th Oct 20147:00 amRNS5 year contract: Prudential Investment Managers
20th Oct 20145:04 pmRNSDirector/PDMR Shareholding
16th Oct 20147:00 amRNSQ3 Trading Update
25th Sep 20147:00 amRNS5 year contract renewal with top 10 asset manager
22nd Sep 20147:00 amRNSAppointment of Client Integration Director
8th Sep 201411:59 amRNSDirector/PDMR Shareholding
4th Sep 20147:00 amRNSInformation security accreditation
6th Aug 20147:00 amRNSHalf Yearly Report
21st Jul 20147:00 amRNSMajor new StatPro Revolution contract in Europe
16th Jul 20147:00 amRNSTrading Update and Notice of Results
25th Jun 20147:00 amRNSCapita integrates with StatPro Revolution
20th Jun 20143:09 pmRNSPurchase of own shares (Replacement)
20th Jun 20142:39 pmRNSPurchase of own shares
19th Jun 20147:00 amRNSSenior Appointment
4th Jun 20149:50 amRNSDirector/PDMR Shareholding
14th May 20144:45 pmRNSResult of AGM
14th May 20147:00 amRNSAGM Statement
9th Apr 20144:08 pmRNSPosting of Annual Report and Notice of AGM
13th Mar 20141:29 pmRNSChange of Registered Office
12th Mar 20147:00 amRNSFinal Results
7th Mar 20147:15 amRNSHolding(s) in Company
23rd Jan 20147:00 amRNSTrading Update and Notice of Results
27th Nov 201311:07 amRNSDirector/PDMR Shareholding
18th Oct 20137:00 amRNSQ3 Trading Update
3rd Oct 20139:11 amRNSDirector/PDMR Shareholding
27th Sep 20138:39 amRNSDirector/PDMR Shareholding
12th Sep 201311:57 amRNSHolding(s) in Company
9th Sep 201312:24 pmRNSDirector/PDMR Shareholding
31st Jul 20137:00 amRNSHalf Yearly Report
16th Jul 20137:00 amRNSTrading Update and Notice of Results
16th Jul 20137:00 amRNSUpdate on acquisition of SiSoft
12th Jun 20134:36 pmRNSDirector/PDMR Shareholding
3rd May 20137:00 amRNSResult of AGM
2nd May 20137:00 amRNSAGM Statement
4th Apr 20135:01 pmRNSPosting of Annual Report and Notice of AGM
19th Mar 20137:00 amRNSPartnership with Interactive Data
15th Mar 201310:14 amRNSDirector/PDMR Shareholding
13th Mar 20137:00 amRNSFinal Results
23rd Jan 20137:00 amRNSTrading Update & Notice of Results
20th Dec 20124:21 pmRNSDirector/PDMR Shareholding
12th Dec 201212:05 pmRNSHolding(s) in Company
12th Dec 20129:50 amRNSGrant of options
4th Dec 20127:00 amRNSDirectorate Change
22nd Nov 201211:15 amRNSDirector/PDMR Shareholding
15th Nov 20123:09 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.